From LDN Science.
Two-day summit of specialists in fibromyalgia and chronic fatigue syndrome concludes: LDN is the top choice for treatment of chronic pain in these patients.
In a recent story, Medscape News Reporter Miriam E. Tucker shares new insights into LDN’s use for treatment of chronic pain conditions.
University of Alabama’s Neuroinflammation, Pain and Fatigue Lab’s director, Jarred W. Younger (PhD), believes that LDN could be good news for patients of chronic pain in the form of an affordable alternative to the conventionally available opioid. Usage of LDN could prove to be positively life changing for patients of conditions such as ME/CFS and Fibromyalgia.
There is a need for further studies to reach any final conclusions but the current findings are promising. When compared to other opioids, LDN shows much better long-term results due to the fact that it does not cause pain sensitivity like most opioids do. On the contrary, it reduces sensitivity to pain over the course of time according to Jarred W. Younger.
To read the rest of this story, click on the link below: